Rapid DOTS expansion in India

Bulletin of the World Health Organization

Volumn 80, Issue 6, 2002, Pages 457-463

  Khatri, G R ^a   Frieden, Thomas R ^b,c,d  

^a GOVERNMENT OF INDIA   (India)

^b WHO Regional Office for South East Asia   (India)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

BC6 vaccine; Clinical trials, Phase I; Drug evaluation, Preclinical; Models, Animal; Mycobacterium; Mycobacterium bovis immunology genetics; Research (source: MeSH, NLM); Tuberculosis immunology genetics

Indexed keywords

BCG VACCINE;

DISEASE CONTROL; DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC HEALTH; TUBERCULOSIS;

DRUG SCREENING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENETICS; INDIA; INFECTION CONTROL; MONITORING; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; DIRECTLY OBSERVED THERAPY; HEALTH PRIORITIES; HUMANS; INDIA; PROGRAM EVALUATION; TUBERCULOSIS; URBAN HEALTH SERVICES;

INDIA;

EID: 0036270989     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Self-administration of medicaments. A review of published work and a study of the problems
2. Tuberculosis treatment in Nepal: A rapid assessment of government centres using different types of patient supervision
3. Tuberculosis clinics
4. Private doctors and tuberculosis control in India
5. Surveillance of drug resistance in tuberculosis in the State of Tamil Nadu
6. The global epidemiology of HIV/AIDS
7. Risk of development of tuberculosis in HIV-infected patients